Recursion Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Recursion Pharmaceuticals Inc
TickerRXRX
CIK #0001601830
CUSIP75629V104
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address41S Rio Grande Street, Salt Lake City, UT 84101
Source [EDGAR]
CIK Filing 2011 - 2024
[0001601830] 10-K
[0001601830] 10-Q
[0001601830] 3
[0001601830] 4
[0001601830] 8-K
[0001601830] D
[0001601830] SC 13D
[0001601830] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Kinnevik AB PUBL Recursion Pharmaceuticals Inc [2023-05-22] 5.6
Vanguard Group Inc Recursion Pharmaceuticals Inc [2023-02-09] 5.54
BlackRock Inc Recursion Pharmaceuticals Inc [2023-02-03] 5.9
Data Collective IV LP Recursion Pharmaceuticals Inc [2022-02-14] 3.7
Lux Capital Management LLC Recursion Pharmaceuticals Inc [2022-02-14] 8.2
Baillie Gifford & Co Recursion Pharmaceuticals Inc [2021-05-06] 10.89
Mubadala Investment Co PJSC Recursion Pharmaceuticals Inc [2021-04-26] 5.7
Form 3/4/5 Filer 2011 - 2024
Recursion Pharmaceuticals Inc
Gibson Christopher
Mauro David J
Virani Shafique
Larson Tina Marriott
Borgeson Blake
Secora Michael
Li Dean Y
Dar Zavain
Bogue Zachary
Chavez R Martin
Mubadala Investment Co PJSC
Mamoura Diversified Global Holding PJSC
Burrell Terry-Ann
Hershberg Robert
Doyle Ramona
Lux Co-Invest Opportunities, L.P.
Wolfe Josh
Hebert Peter
Lux Co-Invest Partners, LLC
Lux Venture Partners IV, LLC
Lux Ventures IV, L.P.
MIC Capital Partners Public US IM LLC
DCVC Opportunity Fund II, L.P.
DCVC Opportunity Fund II GP, LLC
DCVC V GP LLC
Ocko Matthew
DCVC V LP
Data Collective IV, L.P.
Data Collective IV GP, LLC
Form 13F Holdings
Firm Period DFND Voting Shares
Baillie Gifford & Co [2023-03-31] SOLE 16,670,409.0 16,670,409.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 10,748,375.0
BlackRock Inc. [2023-03-31] SOLE 10,366,798.0 10,631,857.0
Baillie Gifford & Co [2023-03-31] DFND 8,423,732.0 8,465,121.0
MIC Capital Management UK LLP [2023-03-31] SOLE 8,451,758.0 8,451,758.0
Kinnevik AB (publ) [2023-03-31] DFND 7,653,061.0 7,653,061.0
State Street Corp [2023-03-31] DFND 6,143,330.0 6,372,515.0
Data Collective IV GP, LLC [2023-03-31] SOLE 5,941,120.0 5,941,120.0
Laurion Capital Management LP [2023-03-31] SOLE 4,825,735.0 4,825,735.0
FMR LLC [2023-03-31] DFND 4,731,366.0 4,755,461.0
ARK Investment Management LLC [2023-03-31] SOLE 3,576,862.0 3,576,862.0
Platinum Investment Management Ltd [2023-03-31] SOLE 2,725,157.0 2,770,451.0
Geode Capital Management LLC [2023-03-31] DFND 2,743,484.0 2,743,484.0
MV Management Xi LLC [2023-03-31] SOLE 1,971,908.0 1,971,908.0
Credit Suisse AG [2023-03-31] DFND 1,564,017.0 1,582,373.0
Harvard Management Co Inc [2023-03-31] SOLE 1,509,254.0 1,509,254.0
Duquesne Family Office LLC [2023-03-31] DFND 1,385,950.0 1,385,950.0
Northern Trust Corp [2023-03-31] DFND 31,416.0 1,153,810.0
ArchPoint Investors [2023-03-31] SOLE 1,114,626.0 1,114,626.0
Comprehensive Financial Management LLC [2023-03-31] SOLE 1,109,395.0 1,109,395.0
Nuveen Asset Management LLC [2023-03-31] DFND 1,025,585.0 1,025,585.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 983,939.0 983,939.0
Cercano Management LLC [2023-03-31] SOLE 978,051.0 978,051.0
Citigroup Inc [2023-03-31] DFND 688,225.0 688,225.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 637,414.0 664,133.0
Citadel Advisors LLC [2023-03-31] DFND 650,715.0 650,715.0
Millennium Management LLC [2023-03-31] SOLE 646,610.0 646,610.0
Bank of America Corp /DE/ [2023-03-31] DFND 33,990.0 557,010.0
Bank of New York Mellon Corp [2023-03-31] DFND 435,421.0 528,955.0
Goldman Sachs Group Inc [2023-03-31] DFND 523,700.0 523,840.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com